$36.20 Million in Sales Expected for Castlight Health Inc (CSLT) This Quarter
Equities analysts forecast that Castlight Health Inc (NYSE:CSLT) will post sales of $36.20 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Castlight Health’s earnings, with the highest sales estimate coming in at $36.29 million and the lowest estimate coming in at $36.11 million. Castlight Health reported sales of $29.90 million during the same quarter last year, which indicates a positive year over year growth rate of 21.1%. The company is scheduled to report its next quarterly earnings results after the market closes on Wednesday, February 21st.
According to Zacks, analysts expect that Castlight Health will report full-year sales of $36.20 million for the current year, with estimates ranging from $130.53 million to $132.00 million. For the next year, analysts forecast that the company will post sales of $159.55 million per share, with estimates ranging from $156.40 million to $164.80 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that cover Castlight Health.
A number of research firms have recently weighed in on CSLT. Cantor Fitzgerald restated a “hold” rating and set a $5.00 target price on shares of Castlight Health in a research report on Wednesday, October 25th. Zacks Investment Research downgraded Castlight Health from a “buy” rating to a “hold” rating in a research report on Thursday. BidaskClub downgraded Castlight Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, November 9th. Canaccord Genuity restated a “buy” rating and set a $7.00 target price on shares of Castlight Health in a research report on Thursday, October 26th. Finally, Chardan Capital dropped their target price on Castlight Health from $6.50 to $6.30 and set a “buy” rating for the company in a research report on Thursday, October 26th. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $5.11.
In related news, CFO Mangini Siobhan Nolan sold 8,866 shares of the company’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $3.70, for a total value of $32,804.20. Following the completion of the sale, the chief financial officer now owns 78,561 shares in the company, valued at $290,675.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO John C. Doyle sold 13,686 shares of the company’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.71, for a total value of $50,775.06. Following the completion of the sale, the chief executive officer now owns 123,705 shares of the company’s stock, valued at approximately $458,945.55. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,778 shares of company stock valued at $84,411. 37.43% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Voya Investment Management LLC increased its holdings in Castlight Health by 25.4% in the second quarter. Voya Investment Management LLC now owns 26,929 shares of the software maker’s stock valued at $112,000 after purchasing an additional 5,453 shares during the last quarter. Nationwide Fund Advisors increased its holdings in Castlight Health by 49.5% in the second quarter. Nationwide Fund Advisors now owns 36,418 shares of the software maker’s stock valued at $151,000 after purchasing an additional 12,061 shares during the last quarter. Stifel Financial Corp increased its holdings in Castlight Health by 12.3% in the second quarter. Stifel Financial Corp now owns 41,000 shares of the software maker’s stock valued at $171,000 after purchasing an additional 4,500 shares during the last quarter. First Quadrant L P CA bought a new stake in Castlight Health in the fourth quarter valued at about $167,000. Finally, UBS Asset Management Americas Inc. bought a new stake in Castlight Health in the second quarter valued at about $193,000. Institutional investors and hedge funds own 42.51% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “$36.20 Million in Sales Expected for Castlight Health Inc (CSLT) This Quarter” was first published by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://www.watchlistnews.com/36-20-million-in-sales-expected-for-castlight-health-inc-cslt-this-quarter/1842997.html.
About Castlight Health
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.